FundedIQ
Biotechnology

Artelo Biosciences: Funding, Investors & Team (Oct 2026)

Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Its programmes have the potential to dramatically improve patient care in major markets.

artelobio.com LinkedIn La Jolla, United States 11-50 employees
Biotechnology Life Science Pharmaceutical B2B
Total raised
$11.0M
Rounds
1
Latest
Undisclosed round
Mar 2026

Artelo Biosciences has raised $11.0M across 1 funding round on record, the most recent an undisclosed round of $11.0M announced in Mar 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Artelo Biosciences Company Profile and Key Stats

Total funding raised
$11.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$11.0M in Mar 2026
Employees
11-50
reported band
Headquarters
La Jolla, United States

Latest funding round on record: Mar 2026.

Artelo Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
$11.0M

Artelo Biosciences Founders and Leadership Team

Name
Role
Contact
Gregory Gorgas
Founder
Locked

Contact details for the Artelo Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Artelo Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Artelo Biosciences' latest round of $11.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Artelo Biosciences in Biotechnology and La Jolla

Companies Similar to Artelo Biosciences

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Artelo Biosciences Funding FAQs

What does Artelo Biosciences do?

Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Its programmes have the potential to dramatically improve patient care in major markets.

How much funding has Artelo Biosciences raised?

Artelo Biosciences has raised $11.0M across 1 round on record. The most recent is an undisclosed round of $11.0M announced in Mar 2026.

When did Artelo Biosciences last raise funding?

Artelo Biosciences' most recent funding round on record is an undisclosed round of $11.0M, announced in Mar 2026.

Who founded Artelo Biosciences?

FundedIQ lists Gregory Gorgas (Founder) at Artelo Biosciences.

Where is Artelo Biosciences headquartered?

Artelo Biosciences is based in La Jolla, California, United States.

How many employees does Artelo Biosciences have?

Artelo Biosciences is in the 11-50 employee band.

How does Artelo Biosciences' funding compare to other Biotechnology startups?

Artelo Biosciences' latest round of $11.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Artelo Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artelo Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.